Tampa, Fla., USA (PRWEB) November 12, 2013
ISPE announced today that it has named Dr. Thomas Zimmer to the newly-created position of Vice President of European Operations. In his role, Dr. Zimmer will be responsible for leading ISPE’s business development and advancing strategic relationships in Europe. Dr. Zimmer began his work by engaging with global Members at ISPE’s Annual Meeting in Washington, DC. When he returns to Europe, Dr. Zimmer will work closely with ISPE’s volunteer and staff advisory teams, industry representatives, regulatory organizations and Member groups to strengthen ISPE’s relationships and deliver increasing value to ISPE’s European stakeholders. Dr. Zimmer will also serve as the primary European liaison to ISPE’s headquarters in Tampa, Fla. USA.
“Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large,” said ISPE President and CEO Nancy S. Berg. “Thomas’s first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world.”
Dr. Zimmer joins ISPE with more than 30 years of experience in the pharmaceutical industry. He is a licensed pharmacist and Qualified Person. Prior to joining ISPE, Dr. Zimmer was Senior Vice President at Boehringer Ingelheim. During his 32 years with the company, he gained experience in development, production, quality and supply chain operations. Prior to becoming Senior Vice President, Dr. Zimmer served as Plant Manager in France, and he was International Project Leader for the Production Alliance Europe. He worked in various cultural environments in North America, South America and several countries in Europe. He holds a PhD in Pharmaceutical Technology from the University of Frankfurt am Main.
In addition to his professional experience, Dr. Zimmer has held numerous advisory posts within the pharmaceutical industry. He is a current member of the ISPE European Forum, a contributor to the ISPE Regulatory and Compliance Committee and a current member and former chair of the ISPE International Leadership Forum. Additionally, he is the former chair of the industrial advisory board of the University of Applied Sciences at the Beuth Institute in Berlin, former chair of the EFPIA Anti-counterfeiting working group, a former member of the WHO IMPACT taskforce, group regulatory enforcement, former chair of the board of directors for the PSI (Pharmaceutical Security Institute) and a former member in the EFPIA manufacturing GMP working group, product lifecycle team, technical development and operations committee TDOC. Dr. Zimmer has been an ISPE Member since 2005.
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA. Visit http://www.ISPE.org for more information.
Read the full story at http://www.prweb.com/releases/2013/11/prweb11325365.htm.
Copyright©2012 Vocus, Inc.
All rights reserved